The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for M Philpott


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.EBI
Glaxosmithkline
Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.EBI
Pfizer
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.EBI
University of Oxford
Selective inhibition of BET bromodomains.EBI
University of Oxford
Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.EBI
Cancer Research Uk Cancer Therapeutics Unit
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.EBI
University of Oxford
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.EBI
University of Oxford
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.EBI
University of Oxford
The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains.EBI
University of Oxford
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.EBI
University of Oxford
Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.EBI
University of Cambridge
Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activityBDB
Neuraxon